Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure

Ole A Breithardt1, Christoph Stellbrink, Lieven Herbots

  • 1Department of Cardiology, University Hospital Aachen, Aachen, Germany. olebreithardt@gmx.de

Insights

Cardiac resynchronization therapy (CRT) can reverse abnormal myocardial strain patterns caused by left bundle branch block (LBBB). This study shows CRT normalizes septal-lateral strain differences, potentially improving patient selection for this heart failure treatment.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Dilated hearts with left bundle branch block (LBBB) exhibit abnormal myocardial strain distribution.
  • The impact of cardiac resynchronization therapy (CRT) on these abnormal strain patterns remains unclear.

Purpose of the Study:

  • To investigate the effects of CRT on regional myocardial strain distribution.
  • To assess changes in strain rate (SR) and strain using echocardiography before and after CRT in patients with LBBB.

Main Methods:

  • Studied 18 patients with symptomatic systolic heart failure and LBBB.
  • Utilized Doppler myocardial imaging to obtain longitudinal systolic velocity, SR, and strain data from septal and lateral walls.
  • Acquired data before and after CRT implementation.

Main Results:

  • Before CRT, the mid-lateral wall showed significantly higher peak SR and strain compared to the mid-septal wall.
  • CRT reversed this septal-lateral difference, normalizing strain distribution.
  • The septal-lateral difference in mid-segmental peak strain changed significantly after CRT.

Conclusions:

  • Left bundle branch block induces significant, abnormal redistribution of myocardial fiber strains.
  • CRT effectively reverses these abnormal septal-lateral strain relationships.
  • Identifying specific reversible strain patterns noninvasively may enhance patient selection for CRT.
Abstract

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...